Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-006135
Filing Date
2020-05-15
Accepted
2020-05-15 20:56:13
Documents
1
Period of Report
2020-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3880
  Complete submission text file 0001179110-20-006135.txt   5214
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACORDA THERAPEUTICS, INC. 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address
Wasman Jane (Reporting) CIK: 0001352455 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 20887527